5 Stocks Under $10 Set to Soar
Ampio Pharmaceuticals
An under-$10 stock in the biotechnology and drugs complex that's close to triggering a major breakout trade is Ampio Pharmaceuticals (AMPE), which is engaged in discovering and developing pharmaceutical drugs and diagnostic products to identify, treat, and prevent a range of human diseases including metabolic disorders, eye disease, kidney disease, acute and chronic inflammation, and male sexual dysfunction. This stock has been acting weak so far in 2012, with shares down by around 14% so far.
If you take a look at the chart for Ampio Pharmaceuticals, you'll notice that this stock has started to uptrend since mid-August, with shares soaring from $2.55 to its recent high of $3.70 a share. During that uptrend, shares of AMPE have been mostly making higher lows and higher highs, which is bullish technical price action. That move has now pushed AMPE within range of triggering a big near-term breakout trade.
Traders should now look for long-biased trades in AMPE once it breaks out above some near-term overhead resistance at $3.65 a share with high volume. Look for a sustained move or close above $3.65 with volume that hits near or above its three-month average action of 652,983 shares. If that breakout triggers soon, then AMPE will have a great chance of trending up towards its next significant overhead resistance levels at $5.29 to $6.25 a share.
At last check, shares of AMPE have hit an intraday high of $3.70 and volume has already hit over 800,000 shares. If AMPE can hold these gains today, then it could be in the early stages of triggering that breakout. Traders can now look to buy AMPE off weakness, and simply use a stop somewhere below today's low of 3.40 a share. Traders can also look for long-biased trades as long as AMPE is trending above $3.65 with strong upside volume.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV